The Court clarified that even where medicinal products for human use fall within the scope of
Directive 2001/83, they can also fall within the scope of Directive 2005/29/EC concerning unfair
business‐to‐consumer commercial practices in the internal market.
http://www.korhazszovetseg.hu/ci/assets/pdf/uploads/HOPE_Newsletter_n___131_-_November_2015.pdf
http://www.korhazszovetseg.hu/ci/assets/pdf/uploads/HOPE_Newsletter_n___131_-_November_2015.pdf
No comments:
Post a Comment